BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM. Skp2 in the ubiquitin-proteasome system: A comprehensive review. Med Res Rev 2020;40:1920-49. [PMID: 32391596 DOI: 10.1002/med.21675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 He DH, Chen YF, Zhou YL, Zhang SB, Hong M, Yu X, Wei SF, Fan XZ, Li SY, Wang Q, Lu Y, Liu YQ. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer. Cancer Sci 2021;112:3218-32. [PMID: 34080260 DOI: 10.1111/cas.15005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Zhou Y, Gao X, Yuan M, Yang B, He Q, Cao J. Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy. Front Pharmacol 2021;12:748852. [PMID: 34658888 DOI: 10.3389/fphar.2021.748852] [Reference Citation Analysis]
3 Maimaitirexiati G, Tian P, Maimaiti H, Ding L, Ma C, Li Y, Wang J, Yan Q, Li R. Expression and correlation analysis of Skp2 and CBX7 in cervical cancer. J Clin Pathol 2021:jclinpath-2021-207752. [PMID: 34281957 DOI: 10.1136/jclinpath-2021-207752] [Reference Citation Analysis]
4 Liu D, Zhou R, Zhou A. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis. Medicine (Baltimore) 2021;100:e24471. [PMID: 33578541 DOI: 10.1097/MD.0000000000024471] [Reference Citation Analysis]
5 Ding L, Sun R, Yan Q, Wang C, Han X, Cui Y, Li R, Liu J. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein. Aging (Albany NY) 2021;13:6724-39. [PMID: 33621206 DOI: 10.18632/aging.202530] [Reference Citation Analysis]
6 Wang H, Luo J, Tian X, Xu L, Zhai Z, Cheng M, Chen L, Luo S. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation. Biochim Biophys Acta Mol Cell Res 2021;1868:118994. [PMID: 33662413 DOI: 10.1016/j.bbamcr.2021.118994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Park J, Cho J, Song EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res 2020;43:1144-61. [PMID: 33165832 DOI: 10.1007/s12272-020-01281-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
8 Hu K, Li XJ, Asmamaw MD, Shi XJ, Liu HM. Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1. Sci Rep 2021;11:21105. [PMID: 34702937 DOI: 10.1038/s41598-021-00646-3] [Reference Citation Analysis]
9 Jian S, Luo D, Wang Y, Xu W, Zhang H, Zhang L, Zhou X. MiR-337-3p confers protective effect on facet joint osteoarthritis by targeting SKP2 to inhibit DUSP1 ubiquitination and inactivate MAPK pathway. Cell Biol Toxicol 2021. [PMID: 34697729 DOI: 10.1007/s10565-021-09665-2] [Reference Citation Analysis]
10 Wu Y, Zhang Z, Li J, Zhong H, Yuan R, Deng Z, Wu X. Mechanism of Adipose-Derived Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miR-21-5p in Hyperoxia-Induced Lung Injury. Stem Cell Rev Rep 2021. [PMID: 34882302 DOI: 10.1007/s12015-021-10311-x] [Reference Citation Analysis]
11 Guo Y, Wang J, Jia C, Liao Y. SKP2 regulates ZEB1 expression and stimulates eutopic endometrial stromal cell invasion and proliferation of adenomyosis. Reprod Biol 2021;22:100578. [PMID: 34844164 DOI: 10.1016/j.repbio.2021.100578] [Reference Citation Analysis]